KSHV LANA2 Antibody (MA1-16663)

Performance guaranteed

Purchase with confidence, knowing that we stand behind
the performance of our antibodies with the InvitrogenTM
antibody performance guarantee. If an InvitrogenTM antibody
doesn't perform in your experiment as described on our website
or datasheet, we'll replace the product at no cost to you, or
if you prefer, we'll provide you with a credit for a future
purchase.*
Learn more.

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Tested Applications

Dilution *

ELISA (ELISA)

1:100-1:2000

Immunocytochemistry (ICC)

1:10-1:500

Immunofluorescence (IF)

1:10-1:500

Immunohistochemistry (Frozen) (IHC (F))

1:10-1:500

Immunohistochemistry (Paraffin) (IHC (P))

1:10-1:500

Immunoprecipitation (IP)

1:10-1:500

Western Blot (WB)

2-4 µg/ml

* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the
product for use in their own experiment using appropriate negative and positive controls.

Product Specific Information

This antibody cross-reacts with human and mouse viral KSHV.

Background/Target Information

LANA2 (latency-associated nuclear antigen) is an inhibitor of p53-induced transcription in reporter assays and may be an apoptosis antagonist. It is a nuclear protein associated with Kaposi's sarcoma-associated herpes virus (KSHV), or human herpes virus 8. It is found in abundance in the nuclei of cultured cells from KSHV-infected hematopoietic tissues, such as PEL (primary effusion lymphoma) and CD (multicentric Castleman's disease). It does not appear to be expressed in KS (Kaposi's sarcoma) lesions.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.